TokenPost·
Abivax Shares Fall About 9% After Scorpion Research Short Report

The report criticized the clinical development of obefazimod, Abivax’s ulcerative colitis candidate. Scorpion Research disclosed a short position in the company.
Every crypto headline. One feed. Updated every minute.

The report criticized the clinical development of obefazimod, Abivax’s ulcerative colitis candidate. Scorpion Research disclosed a short position in the company.